 | • レポートコード：GIR-105X13142 • 出版社/出版日： / 2021年5月25日 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Chemical & Material |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、オキサリプラチンAPIのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。オキサリプラチンAPIの種類別市場規模（純度≥98％、純度≥99％）、用途別市場規模（オキサリプラチン注射、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・オキサリプラチンAPIの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Scion Pharm Taiwan、Acebright、Sai Phytoceuticals、Nischem International、Polymed Therapeutics、Fresenius Kabi Oncology、Tapi Teva、Heraeus、Shilpa Medicare Limited、Vinkem Labs、Chem Genix、Cipla、Qilu Pharmaceutial、VUAB Pharma、Berr Chemical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：純度≥98％、純度≥99％ ・用途別分析2016年-2026年：オキサリプラチン注射、その他 ・オキサリプラチンAPIの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・オキサリプラチンAPIのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・オキサリプラチンAPIのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・オキサリプラチンAPIの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・オキサリプラチンAPIの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Oxaliplatin API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Oxaliplatin API size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Oxaliplatin API market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Oxaliplatin API market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity ≥ 98 %
Purity ≥ 99 %
Market segment by Application can be divided into
Oxaliplatin Injection
Other
The key market players for global Oxaliplatin API market are listed below:
Scion Pharm Taiwan
Acebright
Sai Phytoceuticals
Nischem International
Polymed Therapeutics
Fresenius Kabi Oncology
Tapi Teva
Heraeus
Shilpa Medicare Limited
Vinkem Labs
Chem Genix
Cipla
Qilu Pharmaceutial
VUAB Pharma
Berr Chemical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Oxaliplatin API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oxaliplatin API Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Market Analysis by Application
1.3.1 Overview: Global Oxaliplatin API Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oxaliplatin Injection
1.3.3 Other
1.4 Global Oxaliplatin API Market Size & Forecast
1.4.1 Global Oxaliplatin API Sales in Value (2016-2026))
1.4.2 Global Oxaliplatin API Sales in Volume (2016-2026)
1.4.3 Global Oxaliplatin API Price by Type (2016-2026) & (USD/Kg)
1.5 Global Oxaliplatin API Production Capacity Analysis
1.5.1 Global Oxaliplatin API Total Production Capacity (2016-2026)
1.5.2 Global Oxaliplatin API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Oxaliplatin API Market Drivers
1.6.2 Oxaliplatin API Market Restraints
1.6.3 Oxaliplatin API Trends Analysis
2 Manufacturers Profiles
2.1 Scion Pharm Taiwan
2.1.1 Scion Pharm Taiwan Details
2.1.2 Scion Pharm Taiwan Major Business
2.1.3 Scion Pharm Taiwan Oxaliplatin API Product and Services
2.1.4 Scion Pharm Taiwan Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Acebright
2.2.1 Acebright Details
2.2.2 Acebright Major Business
2.2.3 Acebright Oxaliplatin API Product and Services
2.2.4 Acebright Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Sai Phytoceuticals
2.3.1 Sai Phytoceuticals Details
2.3.2 Sai Phytoceuticals Major Business
2.3.3 Sai Phytoceuticals Oxaliplatin API Product and Services
2.3.4 Sai Phytoceuticals Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Nischem International
2.4.1 Nischem International Details
2.4.2 Nischem International Major Business
2.4.3 Nischem International Oxaliplatin API Product and Services
2.4.4 Nischem International Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Polymed Therapeutics
2.5.1 Polymed Therapeutics Details
2.5.2 Polymed Therapeutics Major Business
2.5.3 Polymed Therapeutics Oxaliplatin API Product and Services
2.5.4 Polymed Therapeutics Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Fresenius Kabi Oncology
2.6.1 Fresenius Kabi Oncology Details
2.6.2 Fresenius Kabi Oncology Major Business
2.6.3 Fresenius Kabi Oncology Oxaliplatin API Product and Services
2.6.4 Fresenius Kabi Oncology Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Tapi Teva
2.7.1 Tapi Teva Details
2.7.2 Tapi Teva Major Business
2.7.3 Tapi Teva Oxaliplatin API Product and Services
2.7.4 Tapi Teva Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Heraeus
2.8.1 Heraeus Details
2.8.2 Heraeus Major Business
2.8.3 Heraeus Oxaliplatin API Product and Services
2.8.4 Heraeus Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Shilpa Medicare Limited
2.9.1 Shilpa Medicare Limited Details
2.9.2 Shilpa Medicare Limited Major Business
2.9.3 Shilpa Medicare Limited Oxaliplatin API Product and Services
2.9.4 Shilpa Medicare Limited Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Vinkem Labs
2.10.1 Vinkem Labs Details
2.10.2 Vinkem Labs Major Business
2.10.3 Vinkem Labs Oxaliplatin API Product and Services
2.10.4 Vinkem Labs Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Chem Genix
2.11.1 Chem Genix Details
2.11.2 Chem Genix Major Business
2.11.3 Chem Genix Oxaliplatin API Product and Services
2.11.4 Chem Genix Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Cipla
2.12.1 Cipla Details
2.12.2 Cipla Major Business
2.12.3 Cipla Oxaliplatin API Product and Services
2.12.4 Cipla Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Qilu Pharmaceutial
2.13.1 Qilu Pharmaceutial Details
2.13.2 Qilu Pharmaceutial Major Business
2.13.3 Qilu Pharmaceutial Oxaliplatin API Product and Services
2.13.4 Qilu Pharmaceutial Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 VUAB Pharma
2.14.1 VUAB Pharma Details
2.14.2 VUAB Pharma Major Business
2.14.3 VUAB Pharma Oxaliplatin API Product and Services
2.14.4 VUAB Pharma Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Berr Chemical
2.15.1 Berr Chemical Details
2.15.2 Berr Chemical Major Business
2.15.3 Berr Chemical Oxaliplatin API Product and Services
2.15.4 Berr Chemical Oxaliplatin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Oxaliplatin API Sales by Manufacturer
3.1 Global Oxaliplatin API Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Oxaliplatin API Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Oxaliplatin API
3.4 Market Concentration Rate
3.4.1 Top 3 Oxaliplatin API Manufacturer Market Share
3.4.2 Top 6 Oxaliplatin API Manufacturer Market Share
3.5 Global Oxaliplatin API Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Oxaliplatin API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Oxaliplatin API Market Size by Region
4.1.1 Global Oxaliplatin API Sales in Volume by Region (2016-2026)
4.1.2 Global Oxaliplatin API Revenue by Region (2016-2026)
4.2 North America Oxaliplatin API Revenue (2016-2026)
4.3 Europe Oxaliplatin API Revenue (2016-2026)
4.4 Asia-Pacific Oxaliplatin API Revenue (2016-2026)
4.5 South America Oxaliplatin API Revenue (2016-2026)
4.6 Middle East and Africa Oxaliplatin API Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Oxaliplatin API Sales in Volume by Type (2016-2026)
5.2 Global Oxaliplatin API Revenue by Type (2016-2026)
5.3 Global Oxaliplatin API Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Oxaliplatin API Sales in Volume by Application (2016-2026)
6.2 Global Oxaliplatin API Revenue by Application (2016-2026)
6.3 Global Oxaliplatin API Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Oxaliplatin API Sales by Type (2016-2026)
7.2 North America Oxaliplatin API Sales by Application (2016-2026)
7.3 North America Oxaliplatin API Market Size by Country
7.3.1 North America Oxaliplatin API Sales in Volume by Country (2016-2026)
7.3.2 North America Oxaliplatin API Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Oxaliplatin API Sales by Type (2016-2026)
8.2 Europe Oxaliplatin API Sales by Application (2016-2026)
8.3 Europe Oxaliplatin API Market Size by Country
8.3.1 Europe Oxaliplatin API Sales in Volume by Country (2016-2026)
8.3.2 Europe Oxaliplatin API Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Oxaliplatin API Sales by Type (2016-2026)
9.2 Asia-Pacific Oxaliplatin API Sales by Application (2016-2026)
9.3 Asia-Pacific Oxaliplatin API Market Size by Region
9.3.1 Asia-Pacific Oxaliplatin API Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Oxaliplatin API Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Oxaliplatin API Sales by Type (2016-2026)
10.2 South America Oxaliplatin API Sales by Application (2016-2026)
10.3 South America Oxaliplatin API Market Size by Country
10.3.1 South America Oxaliplatin API Sales in Volume by Country (2016-2026)
10.3.2 South America Oxaliplatin API Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Oxaliplatin API Sales by Type (2016-2026)
11.2 Middle East & Africa Oxaliplatin API Sales by Application (2016-2026)
11.3 Middle East & Africa Oxaliplatin API Market Size by Country
11.3.1 Middle East & Africa Oxaliplatin API Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Oxaliplatin API Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Oxaliplatin API Typical Distributors
12.3 Oxaliplatin API Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Oxaliplatin API Revenue by Type, (USD Million), 2021-2026
Table 2. Global Oxaliplatin API Revenue by Application, (USD Million), 2021-2026
Table 3. Scion Pharm Taiwan Basic Information, Manufacturing Base and Competitors
Table 4. Scion Pharm Taiwan Major Business
Table 5. Scion Pharm Taiwan Oxaliplatin API Product and Services
Table 6. Scion Pharm Taiwan Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Acebright Basic Information, Manufacturing Base and Competitors
Table 8. Acebright Major Business
Table 9. Acebright Oxaliplatin API Product and Services
Table 10. Acebright Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Sai Phytoceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Sai Phytoceuticals Major Business
Table 13. Sai Phytoceuticals Oxaliplatin API Product and Services
Table 14. Sai Phytoceuticals Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nischem International Basic Information, Manufacturing Base and Competitors
Table 16. Nischem International Major Business
Table 17. Nischem International Oxaliplatin API Product and Services
Table 18. Nischem International Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Polymed Therapeutics Basic Information, Manufacturing Base and Competitors
Table 20. Polymed Therapeutics Major Business
Table 21. Polymed Therapeutics Oxaliplatin API Product and Services
Table 22. Polymed Therapeutics Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Kabi Oncology Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Kabi Oncology Major Business
Table 25. Fresenius Kabi Oncology Oxaliplatin API Product and Services
Table 26. Fresenius Kabi Oncology Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Tapi Teva Basic Information, Manufacturing Base and Competitors
Table 28. Tapi Teva Major Business
Table 29. Tapi Teva Oxaliplatin API Product and Services
Table 30. Tapi Teva Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Heraeus Basic Information, Manufacturing Base and Competitors
Table 32. Heraeus Major Business
Table 33. Heraeus Oxaliplatin API Product and Services
Table 34. Heraeus Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Shilpa Medicare Limited Basic Information, Manufacturing Base and Competitors
Table 36. Shilpa Medicare Limited Major Business
Table 37. Shilpa Medicare Limited Oxaliplatin API Product and Services
Table 38. Shilpa Medicare Limited Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Vinkem Labs Basic Information, Manufacturing Base and Competitors
Table 40. Vinkem Labs Major Business
Table 41. Vinkem Labs Oxaliplatin API Product and Services
Table 42. Vinkem Labs Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Chem Genix Basic Information, Manufacturing Base and Competitors
Table 44. Chem Genix Major Business
Table 45. Chem Genix Oxaliplatin API Product and Services
Table 46. Chem Genix Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Cipla Basic Information, Manufacturing Base and Competitors
Table 48. Cipla Major Business
Table 49. Cipla Oxaliplatin API Product and Services
Table 50. Cipla Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Qilu Pharmaceutial Basic Information, Manufacturing Base and Competitors
Table 52. Qilu Pharmaceutial Major Business
Table 53. Qilu Pharmaceutial Oxaliplatin API Product and Services
Table 54. Qilu Pharmaceutial Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. VUAB Pharma Basic Information, Manufacturing Base and Competitors
Table 56. VUAB Pharma Major Business
Table 57. VUAB Pharma Oxaliplatin API Product and Services
Table 58. VUAB Pharma Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Berr Chemical Basic Information, Manufacturing Base and Competitors
Table 60. Berr Chemical Major Business
Table 61. Berr Chemical Oxaliplatin API Product and Services
Table 62. Berr Chemical Oxaliplatin API Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Oxaliplatin API Sales by Manufacturer (2019-2021e) & (MT)
Table 64. Global Oxaliplatin API Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Oxaliplatin API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Oxaliplatin API Production Capacity by Company, (MT): 2020 VS 2021
Table 67. Head Office and Oxaliplatin API Production Site of Key Manufacturer
Table 68. Global Oxaliplatin API Sales by Region (2016-2021e) & (MT)
Table 69. Global Oxaliplatin API Sales by Region (2021-2026) & (MT)
Table 70. Global Oxaliplatin API Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Oxaliplatin API Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Oxaliplatin API Sales by Type (2016-2021e) & (MT)
Table 73. Global Oxaliplatin API Sales by Type (2021-2026) & (MT)
Table 74. Global Oxaliplatin API Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Oxaliplatin API Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Oxaliplatin API Price by Type (2016-2021e) & (USD/Kg)
Table 77. Global Oxaliplatin API Price by Type (2021-2026) & (USD/Kg)
Table 78. Global Oxaliplatin API Sales by Application (2016-2021e) & (MT)
Table 79. Global Oxaliplatin API Sales by Application (2021-2026) & (MT)
Table 80. Global Oxaliplatin API Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Oxaliplatin API Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Oxaliplatin API Price by Application (2016-2021e) & (USD/Kg)
Table 83. Global Oxaliplatin API Price by Application (2021-2026) & (USD/Kg)
Table 84. North America Oxaliplatin API Sales by Country (2016-2021e) & (MT)
Table 85. North America Oxaliplatin API Sales by Country (2021-2026) & (MT)
Table 86. North America Oxaliplatin API Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Oxaliplatin API Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Oxaliplatin API Sales by Type (2016-2021e) & (MT)
Table 89. North America Oxaliplatin API Sales by Type (2021-2026) & (MT)
Table 90. North America Oxaliplatin API Sales by Application (2016-2021e) & (MT)
Table 91. North America Oxaliplatin API Sales by Application (2021-2026) & (MT)
Table 92. Europe Oxaliplatin API Sales by Country (2016-2021e) & (MT)
Table 93. Europe Oxaliplatin API Sales by Country (2021-2026) & (MT)
Table 94. Europe Oxaliplatin API Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Oxaliplatin API Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Oxaliplatin API Sales by Type (2016-2021e) & (MT)
Table 97. Europe Oxaliplatin API Sales by Type (2021-2026) & (MT)
Table 98. Europe Oxaliplatin API Sales by Application (2016-2021e) & (MT)
Table 99. Europe Oxaliplatin API Sales by Application (2021-2026) & (MT)
Table 100. Asia-Pacific Oxaliplatin API Sales by Region (2016-2021e) & (MT)
Table 101. Asia-Pacific Oxaliplatin API Sales by Region (2021-2026) & (MT)
Table 102. Asia-Pacific Oxaliplatin API Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Oxaliplatin API Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Oxaliplatin API Sales by Type (2016-2021e) & (MT)
Table 105. Asia-Pacific Oxaliplatin API Sales by Type (2021-2026) & (MT)
Table 106. Asia-Pacific Oxaliplatin API Sales by Application (2016-2021e) & (MT)
Table 107. Asia-Pacific Oxaliplatin API Sales by Application (2021-2026) & (MT)
Table 108. South America Oxaliplatin API Sales by Country (2016-2021e) & (MT)
Table 109. South America Oxaliplatin API Sales by Country (2021-2026) & (MT)
Table 110. South America Oxaliplatin API Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Oxaliplatin API Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Oxaliplatin API Sales by Type (2016-2021e) & (MT)
Table 113. South America Oxaliplatin API Sales by Type (2021-2026) & (MT)
Table 114. South America Oxaliplatin API Sales by Application (2016-2021e) & (MT)
Table 115. South America Oxaliplatin API Sales by Application (2021-2026) & (MT)
Table 116. Middle East & Africa Oxaliplatin API Sales by Country (2016-2021e) & (MT)
Table 117. Middle East & Africa Oxaliplatin API Sales by Country (2021-2026) & (MT)
Table 118. Middle East & Africa Oxaliplatin API Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Oxaliplatin API Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Oxaliplatin API Sales by Type (2016-2021e) & (MT)
Table 121. Middle East & Africa Oxaliplatin API Sales by Type (2021-2026) & (MT)
Table 122. Middle East & Africa Oxaliplatin API Sales by Application (2016-2021e) & (MT)
Table 123. Middle East & Africa Oxaliplatin API Sales by Application (2021-2026) & (MT)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Oxaliplatin API Typical Distributors
Table 127. Oxaliplatin API Typical Customers
List of Figures
Figure 1. Oxaliplatin API Picture
Figure 2. Global Oxaliplatin API Sales Market Share by Type in 2020
Figure 3. Purity ≥ 98 %
Figure 4. Purity ≥ 99 %
Figure 5. Global Oxaliplatin API Sales Market Share by Application in 2020
Figure 6. Oxaliplatin Injection
Figure 7. Other
Figure 8. Global Oxaliplatin API Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 9. Global Oxaliplatin API Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Oxaliplatin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Oxaliplatin API Sales (2016-2026) & (MT)
Figure 30. Global Oxaliplatin API Production Capacity (2016-2026) & (MT)
Figure 31. Global Oxaliplatin API Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Oxaliplatin API Market Drivers
Figure 33. Oxaliplatin API Market Restraints
Figure 34. Oxaliplatin API Market Trends
Figure 35. Global Oxaliplatin API Sales Market Share by Manufacturer in 2020
Figure 36. Global Oxaliplatin API Revenue Market Share by Manufacturer in 2020
Figure 37. Oxaliplatin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Oxaliplatin API Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Oxaliplatin API Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Oxaliplatin API Sales Market Share by Region (2016-2026)
Figure 41. Global Oxaliplatin API Revenue Market Share by Region (2016-2026)
Figure 42. North America Oxaliplatin API Revenue (2016-2026) & (USD Million)
Figure 43. Europe Oxaliplatin API Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Oxaliplatin API Revenue (2016-2026) & (USD Million)
Figure 45. South America Oxaliplatin API Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Oxaliplatin API Revenue (2016-2026) & (USD Million)
Figure 47. Global Oxaliplatin API Sales Market Share by Type (2016-2026)
Figure 48. Global Oxaliplatin API Revenue Market Share by Type (2016-2026)
Figure 49. Global Oxaliplatin API Price by Type (2016-2026) & (USD/Kg)
Figure 50. Global Oxaliplatin API Sales Market Share by Application (2016-2026)
Figure 51. Global Oxaliplatin API Revenue Market Share by Application (2016-2026)
Figure 52. Global Oxaliplatin API Price by Application (2016-2026) & (USD/Kg)
Figure 53. North America Oxaliplatin API Sales Market Share by Country (2016-2026)
Figure 54. North America Oxaliplatin API Revenue Market Share by Country (2016-2026)
Figure 55. North America Oxaliplatin API Sales Market Share by Type (2016-2026)
Figure 56. North America Oxaliplatin API Sales Market Share by Application (2016-2026)
Figure 57. Europe Oxaliplatin API Sales Market Share by Country (2016-2026)
Figure 58. Europe Oxaliplatin API Revenue Market Share by Country (2016-2026)
Figure 59. Europe Oxaliplatin API Sales Market Share by Type (2016-2026)
Figure 60. Europe Oxaliplatin API Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Oxaliplatin API Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Oxaliplatin API Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Oxaliplatin API Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Oxaliplatin API Sales Market Share by Application (2016-2026)
Figure 65. South America Oxaliplatin API Sales Market Share by Country (2016-2026)
Figure 66. South America Oxaliplatin API Revenue Market Share by Country (2016-2026)
Figure 67. South America Oxaliplatin API Sales Market Share by Type (2016-2026)
Figure 68. South America Oxaliplatin API Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Oxaliplatin API Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Oxaliplatin API Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Oxaliplatin API Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Oxaliplatin API Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source